768
Maternal HLA Homozygosity and Mother-Child HLA Concordance Increase Vertical HIV-1 Transmission Risk via Breast Milk
Romel D. Mackelprang*1, G John-Stewart1, M Carrington2, B Richardson1, D Mboi-Ngacha3, J Mabuka3, S Rowland-Jones4, D Wamalwa3, B Lohman-Payne3, and C Farquhar1
1Univ of Washington, Seattle, US; 2NCI-Frederick, MD, US; 3Univ of Nairobi, Kenya; and 4Univ of Oxford, UK
Background: Mother-infant human
leukocyte antigen (HLA) concordance and HLA homozygosity
may increase risk of mother-to-child HIV-1 transmission (MTCT) by reducing alloimmune responses against HIV-1-infected maternal cells
or recognition of viral mutants that have escaped maternal immunity.
Methods: To examine the
influence of HLA concordance and homozygosity on
infant HIV-1 acquisition, HLA typing was performed on mother-infant pairs
enrolled in a perinatal HIV-1 study in Nairobi. Women received zidovudine (AZT) at 34 weeks’ gestation and infant blood
was collected within 48 hours of delivery and at 1, 3, 6, 9, and 12 months
post-partum. Maternal HLA class I typing was conducted following a sequence
specific oligonucleotide probe protocol and infant
typing performed using amplification refractory mutation system polymerase
chain reaction. Mother-child concordancy scores
ranging from 3 to 6 were defined by the number of shared class I alleles at A,
B, and C loci, and maternal homozygosity was defined
as homozygosity at any class I locus versus no homozygosity. Transmission risk was estimated using Cox
proportional hazards and logistic regression models.
Results: Among 300
HIV-1-infected women, 57 (19%)
transmitted HIV-1 to their infants, with 21 (37%) infants infected in utero, 26 (47%) between birth and month 1, and 10 (18%)
after month 1 via breastfeeding. Women who were homozygous at 1 or more loci
had higher plasma HIV-1 RNA at 32 weeks’ gestation (5.0 vs. 4.6 log10 copies/mL,
p = 0.03) and, after adjusting
for maternal viral load, had a significantly greater risk of HIV-1 transmission
overall (adjusted hazard ratio [aHR] = 1.8; 95%
confidence interval [CI] 1.1 to 2.9, p = 0.02) and after month 1 (aHR = 4.6, 95%CI 1.6 to 13.5, p = 0.006). With each additional
mother-infant concordant allele, we observed a trend toward increased risk of
overall mother-to-child HIV-1 transmission (aHR =
1.3; 95%CI 1.0 to 1.6, p = 0.07) and a ~1.6-fold increased late
transmission risk via breast milk (aHR = 1.6, 95%CI
1.1 to 2.4, p
= 0.03).
Conclusions: HIV-1 transmission risk
via breast milk was increased among mother-infant pairs concordant at >3 HLA
class I alleles and among women with HLA homozygosity.
These results suggest a role for alloimune responses
or HLA diversity in protection against infant HIV-1 acquisition, even in the
setting of AZT prophylaxis reducing in utero and intra-partum risk.
|